Global Cancer Supportive Care Products Market is expected to grow to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3%

New York City, New York, Jan 22, 2016: As per the latest market report published by Persistence Market Research, titled “Global Cancer Supportive Care Products Market: High consumption of Erythropoietin Stimulating Agents to drive the market for Global Cancer Supportive Care Drugs,” the global cancer supportive care products market is projected to expand at a CAGR of 4.3% during the forecast period (2015–2021).

Request Customize Full TOC: http://www.persistencemarketresearch.com/toc/5336

Cancer supportive care products are mainly used in the treatment of adverse effects associated with cancer therapy as well as for treatment of symptoms and signs of cancer, such as chemotherapy-induced nausea and vomiting, chemotherapy induced neutropenia and anemia, bone metastasis, hair loss, etc. The cancer supportive care products market accounted for US$ 23, 6002.0 Mn in 2014 and is expected to increase to US$ 31,700.0 Mn by 2021 at a CAGR of 4.3% over the forecast period.

The market for cancer supportive care products, though shrouded by the loss of brands exclusivity of various generic drugs and entry of biosimilar drugs, presents lucrative opportunity, as they offer ease of accessibility, affordability, and administration to potential customers.

The report analyzes the global cancer supportive care products market in terms of market value (US$ Mn), by drug class, disease indication, region, and distribution channels, and provides information regarding regional market dynamics, regulations, PEST analysis, competitive landscape, current trends, market estimations, and forecast.

Among the drug class segments, erythropoietin stimulating agents, such as NeoRecormon, Procrit, and Arsanep, are expected to account for the largest share of the global cancer supportive care products market, followed by granulocyte colony-stimulating factors and others. The erythropoietin stimulating agents segment is expected to gain traction in the near future due to increasing number of patients suffering from chemotherapy-induced neutropenia (low count of neutrophils). Increasing demand for high-quality cancer supportive care products is also influencing manufacturers to opt for better quality active pharmaceutical ingredients and maintain a sterile microbial contamination-free manufacturing space.

Request Sample Report: http://www.persistencemarketresearch.com/samples/5336

By disease indication type, the cancer supportive care products market is segmented into various forms of cancers, such as lung cancer, breast cancer, prostate cancer, etc. Among these, the lung cancer segment is expected to dominate the overall market in future, i.e. by 2021, owing to greater incidences of tobacco smoking cases, rising pollution, and exposure to harmful chemicals and gases released from various industries. The segment is projected to expand at a substantial growth rate over the forecast period. However, breast cancer is also gaining traction due to changing lifestyle, the rise in adoption of hormone replacement therapy, and genetic inheritance of genes such as BRCA1 and BRCA2.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/cancer-supportive-care-products-market.asp

Key market participants covered in the report include Amgen Inc., Johnson & Johnson, Novartis Ag., Baxter International Inc, Fagron Group BV, Teva Pharmaceuticals Industries Ltd, Hoffmann LA- Roche Ltd, APR Applied Pharma Science Research S.A., Acacia Pharma Ltd, and Kyowa Hakko Kirin Co Ltd.

The cancer supportive care products market is segmented as follows:

By Drug Class

Non-steroidal anti-inflammatory drugs
Anti-infective
Anti-emetics
Monoclonal antibodies
Erythropoietin stimulating agents
Opioid analgesics
Bisphosphonates
Granulocyte colony stimulating factors

By Disease Indication

Lung cancer
Breast cancer
Prostate cancer
Liver cancer
Bladder cancer
Leukemia
Ovarian cancer
Melanoma
Others

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Compounding pharmacies

By Region

North America
Latin America
Europe
Asia Pacific
The Middle East & Africa

About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research
305 Broadway
7th Floor
New York City, NY 10007
United States
USA-Canada Toll Free: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com